Analyzing T cells using advanced antibody techniques
Proteome Capture in Hydrogel Beads for High Resolution Single Cell Analysis
This study is working on a new way to look at T cells, which are important for understanding diseases like autoimmune disorders and cancer, by using more types of antibodies to get a clearer picture of how these cells work and vary.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cytorum, INC. NIH-funded |
| Lab location | 1 site (Santa Clara, UNITED STATES) |
| Project ID | NIH-10890177 on NIH RePORTER |
What this research studies
This research focuses on improving the analysis of T cells, which play a crucial role in various diseases, by developing a new method that enhances the use of antibodies in flow cytometry. The approach involves processing samples in a way that allows for a broader range of antibodies to be used, thereby providing a more detailed understanding of T cell diversity and function. By integrating techniques from Western blotting into flow cytometry, the study aims to overcome current limitations in identifying T cell characteristics. This could lead to better insights into autoimmune diseases and cancers.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with autoimmune diseases or cancers who are interested in understanding their T cell profiles.
Not a fit: Patients who do not have autoimmune diseases or cancers may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and targeted treatments for patients with autoimmune diseases and cancers.
How similar studies have performed: Other research has shown promise in enhancing flow cytometry techniques, suggesting that this approach could lead to significant advancements in T cell analysis.
Where this research is happening
Santa Clara, UNITED STATES
- Cytorum, INC. — Santa Clara, United States (Active)
Researchers
- Principal investigator: Krutzik, Peter — Cytorum, INC.
- Study coordinator: Krutzik, Peter
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.